Precipio (PRPO) director Cossman received 416 shares
Insider transactions reported
Jeffrey Cossman (director at Precipio Inc., PRPO) reported that they received 416 shares on Jul 15, 2026. After these transactions the filing shows 16,549 shares held directly.
- Reporting person
- Cossman Jeffrey
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Grant or award (A) | Common Stock1 | +416 | $25.24 | $10.5K | 16,549 direct |
Holdings before and after
- Common Stock: 16,133 to 16,549 direct
Footnotes from the filing
- 1. 416 shares of common stock were granted upon the close of business on July 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-26.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Cossman report in this PRPO Form 4?
Jeffrey Cossman (director at Precipio Inc., PRPO) reported that they received 416 shares on Jul 15, 2026. After these transactions the filing shows 16,549 shares held directly.
How many PRPO shares does Cossman hold after this filing?
The filing shows 16,549 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for PRPO
Across the 12 sessions after earlier PRPO headlines, the stock closed higher 4 times and lower 7 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PRPO | SPY |
|---|---|---|---|
| Jun 12, 2026 | Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meetingand 1 other headline that session | -2.3% | +0.5% |
| May 15, 2026 | Precipio Announces Q1 2026 Financial Results | -9.0% | -1.2% |
| May 14, 2026 | Management team's 2025 market-based Options have vested | -0.3% | +0.8% |
| May 7, 2026 | Precipio Announces Q1-2026 Shareholder Update Call | +1.4% | -0.3% |
| Mar 13, 2026 | Precipio Announces Q4 and year-end 2025 Shareholder Update Call | -6.7% | -0.6% |
| Mar 10, 2026 | Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay | +3.3% | -0.2% |
Earlier insider filings at PRPO
- Jul 16, 2026Director Cohen David Seth was granted 520 shares, increasing direct ownership by 0.95% to 55,199 units (SEC Form 4)
- May 26, 2026Director Sandberg Richard A sold $22,517 worth of shares (900 units at $25.02) (SEC Form 4)
- May 21, 2026Director Sandberg Richard A sold $77,784 worth of shares (3,134 units at $24.82), decreasing direct ownership by 20% to 8,142 units (SEC Form 4)
- Apr 17, 2026SEC Form 4 filed by Valauri Christina Rizopoulos
- Apr 17, 2026SEC Form 4 filed by Cossman Jeffrey
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
Follow PRPO and get a push notification the moment its next story breaks.